Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs